Biopharmaceutical fluid path component provider, BioPure, part of Watson-Marlow Fluid Technology Group (WMFTG), has received the keys for its custom-built facility at Dunsbury Park, with production due to begin in March 2022.   Beginning construction in 2019, the new facility is five times the size of the company’s previous two buildings combined and will provide additional capacity to support the company’s ongoing growth and provide service to its customers.   Comprising 120,000 sq. ft, this ne...